870225 | 16:0 Succinyl PE
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) (sodium salt)

Info
16:0 Succinyl PE
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) (sodium salt)
Data
No
No
C41H77NO11PNa
C 60.50%, H 9.53%, N 1.72%, Na 2.82%, O 21.62%, P 3.81%
>99%
1 Years
-20°C
CAS Number
186800-61-3
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
814.014
813.513
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) (sodium salt)
References
Craparo EF, Teresi G, Licciardi M, Bondí ML, Cavallaro G. Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment. J Biomed Nanotechnol. 2013 Jun;9(6):1107-22. doi: 10.1166/jbn.2013.1608. PMID: 23858977.
PubMed ID: 23858977
Certificates of Analysis
- Certificate of Analysis (Lot No. 870225P-25MG-A-025 and 6172PJA025)
- Certificate of Analysis (Lot No. 870225P-500MG-A-025 and 6172PPA025)
- Certificate of Analysis (Lot No. 870225P-500MG-B-025_ and 6172PPB025)
- Certificate of Analysis (Lot No. 870225P-500MG-C-025 and 6172PPC025)
- Certificate of Analysis (Lot No. 870225P-500MG-A-026 and 6172PPA026)
- Certificate of Analysis (Lot No. 870225P-500MG-B-026 and 6172PPB026)
- Certificate of Analysis (Lot No. 870225P-25MG-A-024 and 6172PJA024)
- Certificate of Analysis (Lot No. 870225P-500MG-A-027 and 6172PPA027)
- Certificate of Analysis (Lot No. 870225P-500MG-B-027 and 6172PPB027)
- Certificate of Analysis (Lot No. 870225P-25MG-C-025 and 6172PJC025)
- Certificate of Analysis (Lot No. 870225P-25MG-A-028 and 6172PJA028)
- Certificate of Analysis (Lot No. 870225P-25MG-B-028 and 6172PJB028)
- Certificate of Analysis (Lot No. 870225P-500MG-B-028 and 6172PPB028)